The effect of N-gamma-phenylpropyl-N-benzyloxy acetamide (W-1372) on experimental atherosclerosis and hypercholesteremia.
D000311:Adrenal Glands / Q000187:drug effects; D000818:Animals; D000924:Anticholesteremic Agents / Q000627:therapeutic use* / Q000633:toxicity; D001011:Aorta / Q000032:analysis; D001835:Body Weight / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D002784:Cholesterol / Q000097:blood; D004032:Diet; D004036:Diet, Atherogenic; D006168:Guinea Pigs; D000882:Haplorhini; D006801:Humans; D006937:Hypercholesterolemia / Q000139:chemically induced / Q000188:drug therapy* / Q000517:prevention & control; D007231:Infant, Newborn; D007234:Infant, Premature; D008055:Lipids / Q000097:blood*; D008099:Liver / Q000187:drug effects; D008107:Liver Diseases; D051379:Mice; D009929:Organ Size; D010743:Phospholipids / Q000097:blood; D011422:Propionates / Q000627:therapeutic use; D011817:Rabbits; D051381:Rats; D013045:Species Specificity; D013950:Thymus Gland / Q000187:drug effects; D000637:Transaminases / Q000032:analysis; D014280:Triglycerides / Q000097:blood
D000924:Anticholesteremic Agents; D008055:Lipids; D010743:Phospholipids; D011422:Propionates; D014280:Triglycerides; D002784:Cholesterol; D000637:Transaminases